v3.26.1
Note 9 - Other Assets
12 Months Ended
Dec. 31, 2025
Notes to Financial Statements  
Other Assets Disclosure [Text Block]

NOTE 9 OTHER ASSETS

 

Intangible assets consist of the following:

 

  

December 31, 2025

 
      

Accumulated

     
  

Cost

  

Amortization

  

Net

 

Patents and trademarks

 $895,789  $547,319  $348,470 

Other intangible assets

  42,386   24,808   17,578 

TOTAL INTANGIBLE ASSETS

 $938,175  $572,127  $366,048 

 

 

  

December 31, 2024

 
      

Accumulated

     
  

Cost

  

Amortization

  

Net

 

Patents and trademarks

 $879,492  $478,250  $401,242 

Other intangible assets

  20,237   15,178   5,059 

TOTAL INTANGIBLE ASSETS

 $899,729  $493,428  $406,301 

 

Amortization expense for the years ended December 31, 2025, and 2024, was $56,639 and $38,280, respectively.

 

Other assets consist of the following:

 

  

December 31, 2025

 
      

Accumulated

     
  

Cost

  

Amortization

  

Net

 

Deferred installation costs

 $186,838  $85,297  $101,541 

Deferred clinical training costs

  1,920   1,138   782 

Deferred sales commissions

  248,827   204,647   44,180 

Prepaid license fee

  249,999   234,972   15,027 

Security deposit

  46,124      46,124 

TOTAL OTHER ASSETS

 $733,708  $526,054  $207,654 

 

  

December 31, 2024

 
      

Accumulated

     
  

Cost

  

Amortization

  

Net

 

Deferred installation costs

 $130,443  $42,555  $87,888 

Deferred clinical training costs

  1,920   498   1,422 

Deferred sales commissions

  183,007   90,993   92,014 

Prepaid license fee

  249,999   218,578   31,421 

Security deposit

  46,124      46,124 

TOTAL OTHER ASSETS

 $611,493  $352,624  $258,869